Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:51 PM
Ignite Modification Date:
2025-12-24 @ 2:51 PM
NCT ID:
NCT00091559
Eligibility Criteria:
Inclusion Criteria:
* Patients with Cutaneous T-cell Lymphoma (Stage 1B or higher)
* Age: over 18 years of age
* Have the ability to swallow capsules.
* You must be at least 3 weeks from any prior chemotherapy or anticancer therapy treatment and have recovered from any side effects of that treatment.
* Patients also require adequate heart, liver, and kidney function.
Exclusion Criteria:
* Pregnant and nursing women and those with known allergy to the study drug are excluded from this study.
* Patients are excluded if they are currently receiving chemotherapy, radiation therapy, or other investigational anti-cancer therapy.
* Patients diagnosed with HIV, active hepatitis or who require intravenous antibiotics or antifungal agents are not permitted.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00091559
Study Brief:
Protocol Section:
NCT00091559